In this episode we feature Sunshine Community Health Center for their monthly check-in with KTNA listeners. In addition to hearing updates on services, jobs and events, we spend the hour discussing the…
Author: admin
-

Bears Sign Transfer Rania Chimonides
Rania Chimonides is one of three newcomers joining Cal volleyball in the spring.
Middle…
Continue Reading
-
Towerborne Launches February 26 with Massive Full Game Update – Xbox Wire
- Towerborne Launches February 26 with Massive Full Game Update Xbox Wire
- Xbox’s Towerborne is switching from a free-to-play game to a paid one The Verge
- Towerborne 1.0 is coming to Xbox, PC, and PS5 this February XboxEra
- Xbox-Published Game…
Continue Reading
-
Statement regarding Glencore plc (“Glencore”) – Rio Tinto
- Statement regarding Glencore plc (“Glencore”) Rio Tinto
- European stocks edge up as Glencore boosts STOXX 600 Business Recorder
- Glencore and Rio Tinto resume talks on $260bn mining megadeal Financial Times
- London midday: Stocks stay up as Glencore surges on potential Rio merger Vox Markets
- Wall Street jostles to advise on Rio-Glencore, eyes $100 million prize By Reuters Investing.com
Continue Reading
-

Michigan Set for Home-Opening Wolverine Invitational
Promotions
Jan. 10
Block Cancer MeetANN ARBOR, Mich. — The University of Michigan women’s track and field team will open the home portion of its schedule, hosting the Wolverine Invitational on Saturday (Jan. 10) at the U-M Indoor Track…
Continue Reading
-

“Harry Potter ”star remembers racist bullying after getting cast: ‘It affected me’
Starring in the Harry Potter films wasn’t always magical for one of the actors.
Katie Leung, who played Cho Chang across five of the movies, remembers experiencing a lot of racist bullying online after she was cast to play the love interest for…
Continue Reading
-

Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactionsDUBLIN ,Jan. 8, 2026 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment ofThomas Riga as Chief Business Officer, effectiveJanuary 1, 2026 .Mr. Riga joined Jazz inApril 2025 through the acquisition ofChimerix Inc. , where he served as chief operating and commercial officer. In that role, he directed corporate strategy including the successful sale ofChimerix to Jazz. In addition to leading the transaction process and alliance management atChimerix , he helped navigate a complex regulatory environment leading to successfulU.S. approval and launch of the first approved therapy for H3K27M-mutant diffuse midline glioma affecting approximately 2,000 children and young adults in theU.S. annually. He brings more than 25 years of experience in the pharmaceutical industry leading sales and marketing, business development, operations, and has held multiple C-suite positions across various organizations. In his role as chief business officer, he will lead execution of corporate development initiatives and drive strategic partnerships for the company.“Tom is an exceptional leader with more than 25 years in the pharmaceutical industry and a proven record of driving strategic transactions,” said
Renee Gala , president and chief executive officer ofJazz Pharmaceuticals . “He combines a passion for patients with deep commercial, operational, and corporate development expertise, having led over$2 billion in business development deals in the past five years. Tom played a pivotal role in the approval and launch of Modeyso™ (dordaviprone), the first treatment for an ultra-rare, aggressive brain tumor affecting primarily children and young adults. His commitment to patients who previously had no options is truly inspiring. I look forward to working with Tom in this new capacity to strengthen our corporate development capabilities and continue bringing innovative medicines to Jazz’s portfolio that transform lives.”“I am honored to take on this new role of chief business officer at Jazz,” said
Mr. Riga . “I’ve been impressed by the strength and vision of Jazz’s leadership team and look forward to advancing the company through innovative strategic transactions that leverage the existing expertise and capabilities of the company. Together, we will continue to build on our proven corporate development engine to deliver shareholder value and, most importantly, make a meaningful impact for patients with unmet medical need.”About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.Contacts:
Jazz Media Contact:Kristin Bhavnani Head ofGlobal Corporate Communications Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141U.S. +1 215 867 4948Jazz Investor Contact:
Jack Spinks Executive Director, Investor RelationsJazz Pharmaceuticals plc
investorinfo@jazzpharma.com
Ireland +353 1 634 3211U.S. +1 650 496 2717
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-appoints-thomas-riga-as-chief-business-officer-302656729.htmlSOURCE
Jazz Pharmaceuticals plc Continue Reading
-

The Rockefeller University » Scientists have gotten good at blocking enzymes to treat disease. Here’s what they need to learn next.
Tarun Kapoor (Credit: Lori Chertoff)
Enzymes are the molecular machines that power life; they build and break down molecules, copy DNA, digest food, and drive virtually every chemical reaction in our cells. For decades, scientists have…
Continue Reading
-

Are you taking supplements correctly? Here’s a guide on their dosage limits | Well actually
There are more than 100,000 supplements on the US market – capsules, powders, tablets and gummies sold to improve or maintain health. Supplements can contain vitamins, minerals, botanicals and amino acids on their own or in various…
Continue Reading

